EV1 DEVELOPMENT OF A GUIDANCE FOR INCLUDING PATIENT-REPORTED OUTCOMES (PROS) IN POST-APPROVAL CLINICAL TRIALS OF ONCOLOGY DRUGS FOR COMPARATIVE EFFECTIVENESS RESEARCH (CER)
Abstract
Authors
E.M. Basch A. Abernethy C.D. Mullins M.R. Tiglao S.R. Tunis